News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
192,538 Results
Type
Article (13889)
Company Profile (26)
Press Release (178623)
Section
Business (54379)
Career Advice (613)
Deals (10652)
Drug Delivery (28)
Drug Development (29503)
Employer Resources (70)
FDA (5123)
Job Trends (4222)
News (100799)
Policy (8835)
Tag
Academia (1073)
Alliances (15004)
Alzheimer's disease (419)
Approvals (5120)
Artificial intelligence (39)
Bankruptcy (72)
Best Places to Work (3357)
Breast cancer (63)
Cancer (393)
Cardiovascular disease (38)
Career advice (512)
CAR-T (29)
Cell therapy (80)
Clinical research (24760)
Collaboration (123)
COVID-19 (1078)
C-suite (29)
Data (490)
Diabetes (63)
Diagnostics (1684)
Drug pricing (32)
Earnings (16467)
Employer resources (64)
Events (22941)
Executive appointments (124)
FDA (5309)
Funding (128)
Gene therapy (58)
GLP-1 (240)
Government (1180)
Healthcare (5641)
Infectious disease (1110)
Inflammatory bowel disease (45)
Interviews (103)
IPO (3916)
Job creations (991)
Job search strategy (454)
Layoffs (75)
Legal (1933)
Lung cancer (53)
Manufacturing (58)
Medical device (3336)
Medtech (3338)
Mergers & acquisitions (6814)
Metabolic disorders (155)
Neuroscience (538)
NextGen Class of 2024 (2035)
Non-profit (1636)
Northern California (355)
Obesity (79)
Opinion (44)
Parkinson's disease (38)
People (18901)
Phase I (5559)
Phase II (10567)
Phase III (10010)
Pipeline (145)
Policy (32)
Postmarket research (1293)
Preclinical (1993)
Press Release (30)
Radiopharmaceuticals (71)
Rare diseases (73)
Real estate (1496)
Regulatory (6168)
Research institute (906)
Resumes & cover letters (82)
Southern California (339)
Startups (1247)
United States (3527)
Vaccines (253)
Weight loss (56)
Date
Today (15)
Last 7 days (142)
Last 30 days (614)
Last 365 days (9153)
2024 (9119)
2023 (10541)
2022 (15317)
2021 (16568)
2020 (15761)
2019 (14458)
2018 (11161)
2017 (10525)
2016 (10136)
2015 (12215)
2014 (8429)
2013 (6478)
2012 (6931)
2011 (7213)
2010 (6290)
Location
Africa (260)
Arizona (32)
Asia (12908)
Australia (2424)
California (821)
Canada (293)
China (95)
Colorado (42)
Connecticut (39)
Europe (43498)
Florida (106)
Georgia (53)
Illinois (112)
Indiana (59)
Japan (37)
Maryland (174)
Massachusetts (606)
Michigan (31)
Minnesota (66)
New Jersey (301)
New York (330)
North Carolina (180)
Northern California (355)
Pennsylvania (227)
South America (392)
Southern California (339)
Texas (93)
Washington State (132)
192,538 Results for "celltech group plc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
FDA
NK CellTech Announces FDA Clearance for Clinical Trial of NK010
On January 17, 2024 , NK CellTech Co., Ltd. (NK CellTech), a leading biotech company focused on the development of NK cellular therapies, is pleased to announce that the FDA has granted clearance for the clinical trial of NK010, the non-genetically modified natural killer cells.
January 22, 2024
·
3 min read
Hemogenyx Pharmaceuticals PLC Announces Operations Update - June 17, 2024
Hemogenyx Pharmaceuticals plc, the clinical stage biopharmaceutical group developing treatments for cancers and viral diseases, is pleased to provide an update on its ongoing activities and progress.
June 17, 2024
·
4 min read
Press Releases
Hemogenyx Pharmaceuticals PLC Announces Ultrafast CAR-T Manufacturing
December 19, 2024
·
5 min read
Press Releases
Hemogenyx Pharmaceuticals PLC Announces Site Initiation Visit Completed
December 9, 2024
·
3 min read
Press Releases
Hemogenyx Pharmaceuticals PLC Announces CBR Macrophage Delivery Update
December 6, 2024
·
3 min read
Press Releases
Hemogenyx Pharmaceuticals PLC Announces Institutional Investment
November 11, 2024
·
3 min read
Press Releases
Hemogenyx Pharmaceuticals PLC Announces Admission of New Ordinary Shares and New ISIN
December 10, 2024
·
3 min read
Press Releases
Hemogenyx Pharmaceuticals PLC Announces Notice of Extraordinary General Meeting
November 22, 2024
·
6 min read
Press Releases
Angle PLC Announces HER2 Presentation at SABCS
December 13, 2024
·
5 min read
Horizon Therapeutics plc Ranks First in Overall Corporate Reputation by Rare Disease Patient Advocacy Groups
Horizon Therapeutics plc (Nasdaq: HZNP) today announced that it ranked first in overall corporate reputation among rare disease patient groups around the world who were familiar with the company.
August 23, 2023
·
4 min read
1 of 19,254
Next
